BQ Blue’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer BloombergQuint’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.
Dolat Capital Report
Sudarshan Chemical Industries Ltd. reported a healthy sales growth of 16.5% YoY to Rs 4.93 billion in a challenging input cost environment. High dependence on China for raw materials coupled with sharp increase in energy costs and unabated logistics challenges led to a weak operating performance with Ebitda de-growing at 21.9% YoY to Rs 529 million.
Gross margins and Ebitda margins saw a contraction of 171 and 516 bps YoY respectively to 41.7% and 10.6%. PAT de-growth was at 25.0% YoY to Rs 228 million.
Rate of benefit under RoDTEP for pigment products notified at 0.80% against 2% previously under MEIS scheme. Increase in short-term borrowings by Rs 1.33 billion, led to over-all gross debt soaring up to Rs 7.9 billion against Rs 6.14 billion in March 21.
Click on the attachment to read the full report:
DISCLAIMER
This report is authored by an external party. BloombergQuint does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the author entity and do not represent the views of BloombergQuint.
Users have no license to copy, modify, or distribute the content without permission of the Original Owner.
As a Subscriber you get
Stories
RECOMMENDED FOR YOU
POPULAR